Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cell Death Discovery|October 21, 2025
APOE4 promotes nigral tau hyperphosphorylation through cholesterol in atherosclerosisShanshan Hu, Xiaojia Peng, Bing Xia, et al.
Cellular Reprogramming|January 5, 2021
Effects of Edaravone on Functional Recovery of a Rat Model with Spinal Cord Injury Through Induced Differentiation of Bone Marrow Mesenchymal Stem Cells into Neuron-Like CellsYumei Li, Laibing Liu, Zijiang Yu, et al.
Neuroscience Letters|July 6, 2024
Low frequency of repetitive trans-spinal magnetic stimulation promotes functional recovery after spinal cord injury in mice through inhibiting TGF-β1/Smad2/3 signaling pathwayGuanhua Jiang, Haiwang Song, Xing Han, et al.
Bioengineered|May 31, 2022
Transformer 2 alpha homolog is a downstream gene of hypoxia-inducible factor 1 subunit alpha and is involved in the progression of pancreatic cancerWenpeng Cao, Shan Lei, Zhirui Zeng, et al.
Aging|September 28, 2023
Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin BWenpeng Cao, Xiaozhong Chen, Chaolun Xiao, et al.
Molecules (Basel, Switzerland)|December 11, 2025
Supramolecular Photosensitizers Based on HMeQ[6] and Their Photodynamic Effects on Triple-Negative Breast Cancer CellsBeibei Song, Qingyi Kong, Bo Xiao, et al.
CNS Neuroscience & Therapeutics|July 31, 2025
APOE4 Exacerbates Cerebral Tau Pathology Through Cholesterol-Induced Degradation of Phosphatase in AtherosclerosisJiuyang Ding, Baofei Sun, Yang Gao, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 TargetsDengxiao Lin, Wenfeng Yu, Jia Yu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Neuroprotective Effects of Rosa roxburghii Tratt Juice Concentrate Powder in Parkinson's Disease Mice via the PI3K/AKT Signaling PathwayTong Jin, Long Liu, Faguang Kuang, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428Dengxiao Lin, Wenfeng Yu, Jia Yu, et al.
Pageof 6